Skip to content

PTSD: all studies

Page 83 of 211: studies 821 to 830 of 2,101, newest first. Back to the PTSD overview

Research

Trauma-Associated Sleep Disturbances: a Distinct Sleep Disorder?

Current Sleep Medicine Reports April 26, 2018 Tara D Rachakonda, Nadir M Balba, Miranda M. Lim

Purpose of review: This paper describes a newly proposed sleep disorder, trauma-associated sleep disorder (TSD). Whether or not this represents a truly unique condition is controversial. In this paper, we describe the overlapping features and differences between TSD, post-traumatic stress disorder (PTSD) and Rapid Eye Movement (REM) sleep behavior disorder (RBD). Recent findings: While REM...

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Frontiers in Pharmacology March 1, 2018 Emmanuelle A. D. Schindler, Ryan M Wallace, Jordan Sloshower et al.

Recent reports on the effects of psychedelic-assisted therapies for mood disorders and addiction, as well as the effects of psychedelics in the treatment of cluster headache, have demonstrated promising therapeutic results. In addition, the beneficial effects appear to persist well after limited exposure to the drugs, making them particularly appealing as treatments for chronic neuropsychiatric...

Treatment of sleep disturbances in trauma-affected refugees: Study protocol for a randomised controlled trial.

Trials November 6, 2017 Hinuga Sandahl, Poul Jennum, Lone Baandrup et al.

Sleep disturbances are often referred to as a hallmark and as core symptoms of post-traumatic stress disorder (PTSD). Untreated sleep disturbances can contribute to the maintenance and exacerbation of PTSD symptoms, which may diminish treatment response and constitute a risk factor for poor treatment outcome. Controlled trials on treatment of sleep disturbances in refugees suffering from PTSD...

Dreaming: a gateway to the unconscious?

Annals of the New York Academy of Sciences October 1, 2017 Steve Paulson, Deirdre Barrett, Kelly Bulkeley et al.

Where do our dreams originate from, and what do they tell us? Is there a universal set of symbols that are common to all dreams, regardless of a person's ethnicity or culture? What does dreaming reveal about the unconscious? Why do some dreams remain etched in our memories, whereas others are almost instantly forgotten? Some scientists have adopted the position that dreams are little more than...

I hurt so: hypnotic interventions and palliative care for traumatic brain injury.

Annals of Palliative Medicine September 12, 2017 Donald Moss

This article presents a case study in which self-hypnosis, hypnosis-assisted psychotherapy, and palliative care strategies were provided within a multi-modal integrative treatment program for a 38-year-old woman with traumatic brain injury (TBI) secondary to motor vehicle accident. Self-hypnosis was helpful in anxiety reduction and pain management. Hypnosis-assisted psychotherapy was beneficial...

'It blows my mind' : intoxicated performances by Ridiculusmus

Performance Research August 18, 2017 Richard Talbot 2 citations

Give Me Your Love by Jon Haynes and David Woods, Artistic Directors of Ridiculusmus, is the second in a trilogy Dialogue As The Embodiment of Love, to be presented in 2018, a series of plays investigating innovative mental health therapies. Give Me Your Love is a response to the first UK trials of MDMA assisted psychotherapy for chronic treatment resistant PTSD. The work has been made in...

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Neuropsychopharmacology April 26, 2017 Robin Carhart-Harris, Guy M. Goodwin 680 citations

Plant-based psychedelics, such as psilocybin, have an ancient history of medicinal use. After the first English language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aids to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before...

Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments.

Neuroscience & Biobehavioral Reviews April 2017 Justine Renard, Christopher Norris, Walter J Rushlow et al.

Growing clinical and pre-clinical evidence points to a critical role for cannabidiol (CBD), the largest phytochemical component of cannabis, as a potential pharmacotherapy for various neuropsychiatric disorders. In contrast to delta-9-tetrahydrocannabinol (THC), which is associated with acute and neurodevelopmental pro-psychotic side-effects, CBD possesses no known psychoactive or...

Post-9/11 Veterans and Their Partners Improve Mental Health Outcomes with a Self-directed Mobile and Web-based Wellness Training Program: A Randomized Controlled Trial.

Journal of Medical Internet Research September 27, 2016 Janet R Kahn, William Collinge, Robert Soltysik

Background: Veterans with history of deployment in the Global War on Terror face significant and ongoing challenges with high prevalences of adverse psychological, physical, spiritual, and family impacts. Together, these challenges contribute to an emerging public health crisis likely to extend well into the future. Innovative approaches are needed that reach veterans and their family members...